These tumor suppressive activities of PKD1 loss are not linked to suppression of pro-proliferative signaling by CTNNB1 or other oncogenic pathways, but associated with increased colon barrier function, increased expression of claudins that mediate increased colon epithelial barrier function, and decreased leukocyte infiltration. The gene discussed is CTNNB1; the disease is neoplasm.